首页> 外文OA文献 >Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry
【2h】

Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry

机译:克罗地亚国家数据和与欧洲实践的比较:来自Carciac同步治疗调查II的数据多中心注册表

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Aims. The Cardiac Resynchronization Therapy (CRT) Survey II was conducted between October 2015 and December 2016 and included data from 11088 CRT implantations from 42 countries. The survey’s aim was to report on current European CRT practice. The aim of this study was to compare the Croatian national CRT practice with the European data. Methods. Five centres from Croatia recruited consecutive patients, in a 15-month period, who underwent CRT implantation, primary or an upgrade. Data were collected prospectively by using online database. Results. A total of 115 patients were included in Croatia, which is 33.2% of all CRT implants in Croatia during the study period (total n=346). Median age of the study population was 67 (61–73) years, and 21.2% were women. Primary heart failure (HF) aetiology was nonischemic in 61.1% of patients, and HF with wide QRS was the most common indication for the implantation (73.5%). 80% of patients had complete left bundle branch block, and over two-third had QRS ≥150 ms. Device-related adverse events were recorded in 4.3% of patients. When compared with European countries, Croatian patients were significantly younger (67 vs. 70 years, p=0.012), had similar rate of comorbidities with the exception of higher prevalence of hypertension. Croatian patients significantly more often received CRT-pacemaker when compared with European population (58.3 vs. 29.9%, OR 3.27, 95%CI 2.25–4.74, p<0.001). Conclusion. Our data indicate strict selection of patients among HF population and adherence to guidelines with exception of higher proportion of CRT-pacemaker implantation. This is likely to be influenced by healthcare organization and reimbursement issues in Croatia.
机译:目标。心脏重新同步治疗(CRT)调查II于2016年10月至2016年12月至2016年12月之间进行,其中包括来自42个国家的11088年CRT植入的数据。调查目的是报告当前的欧洲CRT实践。本研究的目的是将克罗地亚国家CRT实践与欧洲数据进行比较。方法。来自克罗地亚的五个中心招募了连续的患者,在15个月的期间,接受了CRT植入,初级或升级。通过使用在线数据库前瞻性收集数据。结果。克罗地亚共有115名患者,在研究期间,克罗地亚的所有CRT植入物占33.2%(总N = 346)。学习人群的中位年龄为67(61-73)岁,女性是21.2%。在61.1%的患者中,患患者的初始心力衰竭(HF)病毒是非缺血性,并且具有宽QRS的HF是植入(73.5%)最常见的迹象。 80%的患者已经完全左束分支块,三分之二有QRS≥150毫秒。与设备相关的不良事件记录在4.3%的患者中。与欧洲国家相比,克罗地亚患者较年轻(67例,70岁,P = 0.012),具有较高的高血压患病率。克罗地亚患者与欧洲人群相比,克罗地亚患者显着接受CRT-起搏器(58.3〜29.9%,或3.27,95%CI 2.25-4.74,P <0.001)。结论。我们的数据表明,严格选择HF人口中的患者,并遵守指南,具有更高比例的CRT-起搏器植入。这可能受到克罗地亚医疗组织和报销问题的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号